Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Cents and Sensibility - Kimberly and Friends' Consortium -- Ignore unavailable to you. Want to Upgrade?

To: vagabond who wrote (16945)	9/29/1999 11:44:00 AM
From: Mr.Manners	Respond to of 108040

BLTI Wednesday September 29, 10:52 am Eastern Time Biolase wins FDA OK for dental, periodontal lasers NEW YORK, Sept 29 (Reuters) - Biolase Technology Inc. (NasdaqSC:BLTI - news), a maker of lasers for medical and dental use, said it won marketing clearances from U.S. regulators for two laser devices for use in dental cosmetic and soft tissue procedures. TwiLite and HyLite, the San Clemente, Calif.-company's two new light-weight diode lasers, were approved by the U.S. Food and Drug Administration for a variety of dental and periodontal procedures. TwiLite can be used by dentists to perform soft tissue procedures. It is cleared for use in general dental procedures as well as a number of more complex dental operations. The HyLite laser is designed for use in periodontal diseases, which are ''the leading cause of tooth loss in adults,'' according to the American Dental Association. The two lasers were also approved for indications including ear, nose and throat, arthroscopy, gastroenterology, general surgery, dermatology, plastic surgery, podiatry, GI/GU, gynecology, neurosurgery, ophthalmology, pulmonary surgery and urology. Biolase's clearances specifically include sucular debridement, which is the removal of diseased or inflamed soft tissue in the periodontal pockets. More Quotes and News: Biolase Technology Inc (NasdaqSC:BLTI - news) Related News Categories: health, US Market News